Annovis Bio announces $3.4 million registered direct offering of common stock priced at-the-market under the NYSE rules

*
Annovis Bio(NYSE:ANVS [https://seekingalpha.com/symbol/ANVS]) said on Monday it has entered into definitive agreements for a registered direct offering of 1,670,732 shares of common stock at $2.05 per share, the closing price on the NYSE on October 24, 2025.

* The gross proceeds from the offering are expected to be approximately $3.4 million, before deducting placement agent fees and other expenses.
* The company intends to use the net proceeds for working capital and general corporate purposes.
* ANVS -19.02% premarket to $1.66.
* Source: Press Release [https://seekingalpha.com/pr/20279987-annovis-announces-3_4-million-registered-direct-offering-of-common-stock-priced-at-the-market]

MORE ON ANNOVIS BIO

* Seeking Alpha’s Quant Rating on Annovis Bio [https://seekingalpha.com/symbol/ANVS/ratings/quant-ratings]
* Historical earnings data for Annovis Bio [https://seekingalpha.com/symbol/ANVS/earnings]
* Financial information for Annovis Bio [https://seekingalpha.com/symbol/ANVS/income-statement]